Escondido, CA, United States of America

Paul A Barstad



Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 156(Granted Patents)


Location History:

  • Norman, OK (US) (1984)
  • Bountiful, UT (US) (2006)
  • Escondido, CA (US) (1993 - 2007)

Company Filing History:


Years Active: 1984-2007

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Paul A. Barstad

Introduction

Paul A. Barstad is a notable inventor based in Escondido, California. He has made significant contributions to the field of immunology, holding a total of six patents. His work focuses on developing compositions that induce humoral anergy to immunogens, which can have profound implications for treating various antibody-mediated pathologies.

Latest Patents

Barstad's latest patents include a composition for inducing humoral anergy to an immunogen. This composition comprises a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule. The conjugates he has developed possess the specific B cell binding ability of the immunogen but lack T cell epitopes. When introduced into individuals, these conjugates induce humoral anergy to the immunogen. This innovation is particularly useful for treating antibody-mediated pathologies caused by foreign or self-immunogens.

Career Highlights

Throughout his career, Barstad has worked with various organizations, including La Jolla Pharmaceutical Company. His experience in the pharmaceutical industry has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical treatments.

Collaborations

Barstad has collaborated with notable individuals in his field, including G. Michael Iverson and Gilbert M. Iverson. These collaborations have likely enriched his research and development efforts, leading to impactful innovations.

Conclusion

Paul A. Barstad's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in treating antibody-mediated pathologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…